BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 6 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,717 | +1526.3% | 213,409 | +1946.3% | 0.10% | +1940.0% |
| Q2 2023 | $659 | -95.5% | 10,429 | -96.8% | 0.01% | -95.9% |
| Q1 2023 | $14,750 | +114.0% | 327,859 | +108.3% | 0.12% | +22.0% |
| Q4 2022 | $6,894 | -99.2% | 157,367 | +826.3% | 0.10% | +809.1% |
| Q2 2022 | $858,000 | -70.8% | 16,988 | -35.1% | 0.01% | -62.1% |
| Q4 2020 | $2,936,000 | +292.5% | 26,181 | +224.3% | 0.03% | +93.3% |
| Q3 2020 | $748,000 | +156.2% | 8,074 | +115.9% | 0.02% | +87.5% |
| Q2 2020 | $292,000 | – | 3,740 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |